These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32032752)

  • 1. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
    Migliori GB; Tiberi S; Zumla A; Petersen E; Chakaya JM; Wejse C; Muñoz Torrico M; Duarte R; Alffenaar JW; Schaaf HS; Marais BJ; Cirillo DM; Alagna R; Rendon A; Pontali E; Piubello A; Figueroa J; Ferlazzo G; García-Basteiro A; Centis R; Visca D; D'Ambrosio L; Sotgiu G;
    Int J Infect Dis; 2020 Mar; 92S():S15-S25. PubMed ID: 32032752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the screening and treatment of latent multidrug-resistant tuberculosis infection.
    Deng G; Zhang P; Lu H
    Drug Discov Ther; 2022 May; 16(2):52-54. PubMed ID: 35466125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of multi drug resistance tuberculosis in Germany.
    Diel R; Nienhaus A; Lampenius N; Rüsch-Gerdes S; Richter E
    Respir Med; 2014 Nov; 108(11):1677-87. PubMed ID: 25443398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
    Bamrah S; Brostrom R; Dorina F; Setik L; Song R; Kawamura LM; Heetderks A; Mase S
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):912-8. PubMed ID: 25199004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for treating children with drug-resistant tuberculosis.
    Galli L; Lancella L; Garazzino S; Tadolini M; Matteelli A; Migliori GB; Principi N; Villani A; Esposito S;
    Pharmacol Res; 2016 Mar; 105():176-82. PubMed ID: 26821118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis.
    Cain KP; Nelson LJ; Cegielski JP
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):269-74. PubMed ID: 20132616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
    Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.